Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Treatment Efficacy Quality of Life Remission Rates Risk Stratification Mortality Rates Drug Efficacy Efficacy and Safety Gender Differences Treatment Response

4 ARTICLES

last wk.

FDA Approves Takeda’s Orzeyful for Narcolepsy Type 1

The pill is the first oral orexin receptor 2 agonist designed to restore orexin signaling and improve daytime wakefulness in adults with narcolepsy type 1.

6 ARTICLES

4w ago

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

3 ARTICLES

last mo.

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

4 ARTICLES

last mo.

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

3 ARTICLES

2mo ago

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

5 ARTICLES

2mo ago

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

7 ARTICLES

2mo ago

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

6 ARTICLES

2mo ago

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

3 ARTICLES

3mo ago

MD Anderson Maps Triple-Negative Breast Cancer at Single-Cell Resolution and Unveils 13-Gene Model to Predict Chemo Response

6 ARTICLES

3mo ago

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

5 ARTICLES

3mo ago

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

4 ARTICLES

3mo ago

FDA Approves Bizengri for NRG1 Fusion-Positive Cholangiocarcinoma

4 ARTICLES

3mo ago

Study Details VeloCD Blood Method to Predict Illness Trajectory

3 ARTICLES

3mo ago

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

8 ARTICLES

3mo ago

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

19 ARTICLES

3mo ago

FDA Approves First Gene Therapy for Inherited Hearing Loss

4 ARTICLES

3mo ago

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Patient Outcomes

FDA Approves Takeda’s Orzeyful for Narcolepsy Type 1

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

Trodelvy Approved in U.S. and EU as First‑Line Option for Metastatic Triple‑Negative Breast Cancer

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

NHS Approves First New Ovarian Cancer Drug in 20 Years

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

Never miss stories about

Patient Outcomes

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

MD Anderson Maps Triple-Negative Breast Cancer at Single-Cell Resolution and Unveils 13-Gene Model to Predict Chemo Response

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

FDA Approves Bizengri for NRG1 Fusion-Positive Cholangiocarcinoma

Study Details VeloCD Blood Method to Predict Illness Trajectory

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

FDA Approves First Gene Therapy for Inherited Hearing Loss

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Never miss stories about

Patient Outcomes